Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 Receptor Agonists Show Promise as Adjunctive Treatment for Ovarian Cancer Brooke McCormick Rose McNulty Key Takeaways GLP-1 receptor agonists are linked to a 55% reduction in mortality risk in women with ovarian cancer, based on a retrospective cohort study
GLP-1s are also approved to treat moderate to severe obstructive sleep apnea and metabolic-associated steatohepatitis (MASH), which was previously known as fatty liver disease
In 2022, Stark et al
doi: 10.1055/s-2007-979981 60 SlavinBGOngJMKernPA
US$ 20.01
US$ 26.65
US$ 29.88
